The intestinal elimination of ciprofloxacin in the rat.

Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother (2009) 1.11

Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate. Antimicrob Agents Chemother (1997) 0.97

Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract. Antimicrob Agents Chemother (1996) 0.89

Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats. Antimicrob Agents Chemother (1995) 0.89

Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother (1998) 0.87

Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro. Antimicrob Agents Chemother (2013) 0.87

Influence of renal failure on ciprofloxacin pharmacokinetics in rats. Antimicrob Agents Chemother (1998) 0.84

Comparison of models for studying the intestinal elimination of ciprofloxacin in the rat. Drugs (1995) 0.84

Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process. Antimicrob Agents Chemother (1996) 0.84

Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates. Br J Pharmacol (1999) 0.80

Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients. Antimicrob Agents Chemother (1995) 0.80

Sparfloxacin secretion across Caco-2 cells involves a multidrug resistance-like mechanism. Drugs (1995) 0.78

Stereoselectivity of ofloxacin intestinal transport in the rat. Drugs (1995) 0.77

Influence of renal failure on intestinal clearance of ciprofloxacin in rats. Antimicrob Agents Chemother (1999) 0.77

Excretion of ciprofloxacin into the large bowel of the rabbit. Antimicrob Agents Chemother (1996) 0.75

Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA (1998) 3.71

Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis (1989) 3.09

Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun (1987) 2.63

Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun (1987) 2.61

Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis (1999) 2.44

Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agents Chemother (1997) 2.09

Testicular fixation following torsion of the spermatic cord--does it guarantee prevention of recurrent torsion events? J Urol (2006) 2.02

Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Antimicrob Agents Chemother (1990) 1.96

In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother (1992) 1.88

Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits. Antimicrob Agents Chemother (1977) 1.82

Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother (1991) 1.81

A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol (2003) 1.73

Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrob Agents Chemother (1995) 1.66

Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest (1988) 1.55

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother (1993) 1.51

Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications. Isr Med Assoc J (2001) 1.50

In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Antimicrob Agents Chemother (1994) 1.48

Is only meatoplasty a legitimate surgical solution for extreme distal hypospadias? A long-term follow-up after adolescence. BJU Int (2000) 1.45

Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. Antimicrob Agents Chemother (1990) 1.45

Repair of pelvic fracture posterior urethral defects using an elaborated perineal approach: experience with 74 cases. J Urol (1991) 1.44

Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet (1996) 1.42

Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1999) 1.41

Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis (1991) 1.37

Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. Antimicrob Agents Chemother (1987) 1.33

Experimental models of bone and prosthetic joint infections. Clin Infect Dis (1997) 1.33

Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. Antimicrob Agents Chemother (1992) 1.33

Effects of diazepam and midazolam on baroreflex control of heart rate and on sympathetic activity in humans. Anesth Analg (1986) 1.31

Urinomas caused by ureteral injuries: CT appearance. Abdom Imaging (2001) 1.30

Tuberculosis of the sacroiliac joint: clinical features, outcome, and evaluation of closed needle biopsy in 11 consecutive cases. Am J Med (1988) 1.30

Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrob Agents Chemother (1992) 1.29

Complex relationship between acquisition of beta-lactam resistance and loss of virulence in Streptococcus pneumoniae. J Infect Dis (2001) 1.29

Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. Antimicrob Agents Chemother (1985) 1.28

Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrob Agents Chemother (1989) 1.27

Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob Agents Chemother (1997) 1.27

Disparate findings on the role of virulence factors of Enterococcus faecalis in mouse and rat models of peritonitis. Infect Immun (1998) 1.22

Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology (2001) 1.22

Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis. J Infect Dis (1997) 1.22

Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. Prostate (2008) 1.21

Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother (1990) 1.21

Inappropriateness and variability of antibiotic prescription among French office-based physicians. J Clin Epidemiol (1998) 1.21

Trends in antimicrobial drug use in the community--France, 1981-1992. J Infect Dis (1998) 1.20

Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. Antimicrob Agents Chemother (1987) 1.19

In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. Br J Clin Pharmacol (1992) 1.19

Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob Agents Chemother (1998) 1.18

Stereoselective passage of mefloquine through the blood-brain barrier in the rat. J Pharm Pharmacol (1997) 1.17

Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother (2000) 1.16

Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antioxid Redox Signal (2001) 1.16

Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects. Antimicrob Agents Chemother (1988) 1.16

Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits. Antimicrob Agents Chemother (1984) 1.15

Antibiotic use in developing countries. Infect Control Hosp Epidemiol (2000) 1.15

Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother (1999) 1.14

A new model of experimental prosthetic joint infection due to methicillin-resistant Staphylococcus aureus: a microbiologic, histopathologic, and magnetic resonance imaging characterization. J Infect Dis (1996) 1.13

Effects of phenylbutazone on extravascular diffusion, protein binding and urinary excretion of cefazolin in rabbits. J Pharmacol Exp Ther (1981) 1.12

In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother (1999) 1.12

Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir. Antimicrob Agents Chemother (2000) 1.12

Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis. J Antimicrob Chemother (1986) 1.11

Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. J Infect Dis (1994) 1.11

Influence of diet on experimental toxicity of amphotericin B deoxycholate. Antimicrob Agents Chemother (1994) 1.11

Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Ther (1999) 1.11

Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology (1988) 1.10

P-glycoprotein expression of the human placenta during pregnancy. Placenta (2005) 1.09

Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans. Antimicrob Agents Chemother (1985) 1.08

Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis. Antimicrob Agents Chemother (2000) 1.08

High-performance liquid chromatographic method for the determination of cefpodoxime levels in plasma and sinus mucosa. J Chromatogr B Biomed Appl (1994) 1.08

Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide. J Pharmacol Exp Ther (1982) 1.07

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrob Agents Chemother (1996) 1.07

Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother (1996) 1.06

[Acquired toxoplasmosis: a new chemotherapy: the sulfamethoxazole-trimethoprim combination]. Nouv Presse Med (1973) 1.06

Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob Agents Chemother (2001) 1.05

Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol (1992) 1.03

Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother (1996) 1.03

Ceftriaxone diffusion into cardiac fibrin vegetation. Qualitative and quantitative evaluation by autoradiography. Fundam Clin Pharmacol (1991) 1.03

Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochim Biophys Acta (2000) 1.03

Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids (2006) 1.03

Chronic alcoholism increases the induction dose of propofol in humans. Anesth Analg (1993) 1.02

Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture. Antimicrob Agents Chemother (1999) 1.02

In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis (1990) 1.02

Renal disposition of ceftazidime illustrated by interferences by probenecid, furosemide, and indomethacin in rabbits. Antimicrob Agents Chemother (1984) 1.02

Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin Radiol (2006) 1.01

Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary culture. J Pharmacol Exp Ther (1990) 1.01

Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. Antimicrob Agents Chemother (1992) 1.00

Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anesthesiology (1996) 1.00

Toxoplasma gondii infection in advanced HIV infection. AIDS (1994) 0.99

Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis. Antimicrob Agents Chemother (1992) 0.99

Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. Am J Obstet Gynecol (2001) 0.99

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother (2000) 0.98

Tolerance of once-daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers. Clin Pharmacol Ther (1988) 0.98

Incorporation of amphotericin B (AMB) into liposomes alters AMB-induced acute nephrotoxicity in rabbits. J Pharmacol Exp Ther (1989) 0.98

Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses. Antimicrob Agents Chemother (1998) 0.97

Determination of the enantiomers of mefloquine in plasma and whole blood using a coupled achiral-chiral high-performance liquid chromatographic system. J Chromatogr (1990) 0.97

Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun (1997) 0.97

Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding. Antimicrob Agents Chemother (1991) 0.97

Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus. Antimicrob Agents Chemother (2000) 0.96

Metabolic evidence for adaptation to a high protein diet in rats. J Nutr (2001) 0.96

Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci (1994) 0.96

Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms. Clin Infect Dis (1996) 0.96